MAPK14 and prion disease: And since activation of the MAP kinase p38 has been specifically linked to the toxic signaling underlying prion diseases [113, 123, 124], it seems likely that the increase in p38 phosphorylation in our TgN1 mice at terminal prion disease is a consequence of the elevated PrPSc levels.